mgrosva@gmail.com
Since emergence and wide spread dissemination of SARS- COV-2 all efforts
in the scientific community have been focused on understanding the
pathophysiology of the disease, alongside all aspects of a global health
problem and its complexities. More over the scientific community is
trying to accelerate the velocity of knowledge dissemination beyond that
of the virus transcontinental sweep over by various strategies of fast
track, green open access and preprints. At the same time, we must try to
avoid any enticement for exoneration in accuracy and methodological
soundness of the studies.
In this paper we try to raise either a new or under noticed medication
for this disease based on an in-press accepted manuscript of senior
author of this manuscript and some other independent researchers.(1-3)